Singapore markets close in 5 hours 56 minutes

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0001+0.0001 (+9,900.00%)
At close: 10:36AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.09M
Enterprise value 2.55M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.15
Price/book (mrq)0.11
Enterprise value/revenue 0.16
Enterprise value/EBITDA -0.09

Trading information

Stock price history

Beta (5Y monthly) 2.65
52-week change 3-43.75%
S&P500 52-week change 325.59%
52-week high 30.0650
52-week low 30.0001
50-day moving average 30.0090
200-day moving average 30.0104

Share statistics

Avg vol (3-month) 312.68k
Avg vol (10-day) 3N/A
Shares outstanding 5232.41M
Implied shares outstanding 6778.38M
Float 8204.94M
% held by insiders 11.83%
% held by institutions 10.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin -190.00%
Operating margin (ttm)-103.54%

Management effectiveness

Return on assets (ttm)-20.79%
Return on equity (ttm)-74.68%

Income statement

Revenue (ttm)16.14M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)-3.80%
Gross profit (ttm)N/A
EBITDA -16.41M
Net income avi to common (ttm)-30.66M
Diluted EPS (ttm)-0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.94M
Total cash per share (mrq)0.01
Total debt (mrq)2.56M
Total debt/equity (mrq)9.46%
Current ratio (mrq)2.02
Book value per share (mrq)0.12

Cash flow statement

Operating cash flow (ttm)-15.01M
Levered free cash flow (ttm)-8.83M